Skip to main content

AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs.

Publication ,  Journal Article
Kry, SF; Alvarez, P; Cygler, JE; DeWerd, LA; Howell, RM; Meeks, S; O'Daniel, J; Reft, C; Sawakuchi, G; Yukihara, EG; Mihailidis, D
Published in: Med Phys
February 2020

Thermoluminescent dosimeters (TLD) and optically stimulated luminescent dosimeters (OSLD) are practical, accurate, and precise tools for point dosimetry in medical physics applications. The charges of Task Group 191 were to detail the methodologies for practical and optimal luminescence dosimetry in a clinical setting. This includes: (a) to review the variety of TLD/OSLD materials available, including features and limitations of each; (b) to outline the optimal steps to achieve accurate and precise dosimetry with luminescent detectors and to evaluate the uncertainty induced when less rigorous procedures are used; (c) to develop consensus guidelines on the optimal use of luminescent dosimeters for clinical practice; and (d) to develop guidelines for special medically relevant uses of TLDs/OSLDs such as mixed photon/neutron field dosimetry, particle beam dosimetry, and skin dosimetry. While this report provides general guidelines for TLD and OSLD processes, the report provides specific details for TLD-100 and nanoDotTM dosimeters because of their prevalence in clinical practice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Med Phys

DOI

EISSN

2473-4209

Publication Date

February 2020

Volume

47

Issue

2

Start / End Page

e19 / e51

Location

United States

Related Subject Headings

  • Thermoluminescent Dosimetry
  • Reproducibility of Results
  • Remote Sensing Technology
  • Photons
  • Optically Stimulated Luminescence Dosimetry
  • Nuclear Medicine & Medical Imaging
  • Neutrons
  • Models, Theoretical
  • Luminescence
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kry, S. F., Alvarez, P., Cygler, J. E., DeWerd, L. A., Howell, R. M., Meeks, S., … Mihailidis, D. (2020). AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs. Med Phys, 47(2), e19–e51. https://doi.org/10.1002/mp.13839
Kry, Stephen F., Paola Alvarez, Joanna E. Cygler, Larry A. DeWerd, Rebecca M. Howell, Sanford Meeks, Jennifer O’Daniel, et al. “AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs.Med Phys 47, no. 2 (February 2020): e19–51. https://doi.org/10.1002/mp.13839.
Kry SF, Alvarez P, Cygler JE, DeWerd LA, Howell RM, Meeks S, et al. AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs. Med Phys. 2020 Feb;47(2):e19–51.
Kry, Stephen F., et al. “AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs.Med Phys, vol. 47, no. 2, Feb. 2020, pp. e19–51. Pubmed, doi:10.1002/mp.13839.
Kry SF, Alvarez P, Cygler JE, DeWerd LA, Howell RM, Meeks S, O’Daniel J, Reft C, Sawakuchi G, Yukihara EG, Mihailidis D. AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs. Med Phys. 2020 Feb;47(2):e19–e51.

Published In

Med Phys

DOI

EISSN

2473-4209

Publication Date

February 2020

Volume

47

Issue

2

Start / End Page

e19 / e51

Location

United States

Related Subject Headings

  • Thermoluminescent Dosimetry
  • Reproducibility of Results
  • Remote Sensing Technology
  • Photons
  • Optically Stimulated Luminescence Dosimetry
  • Nuclear Medicine & Medical Imaging
  • Neutrons
  • Models, Theoretical
  • Luminescence
  • Humans